(S (NP (NNP Signet) (NN ring) (NML (NN cell) (NN carcinoma))) (VP (VBZ is) (NP (NP (DT a) (NN type)) (PP (IN of) (NP (NP (JJ rare) (NN adenocarcinoma)) (PP (IN with) (NP (JJ poor) (NN prognosis))))))) (. .))
(S (NP (RB Early) (NN detection)) (VP (VBZ leads) (PP (IN to) (NP (NP (JJ huge) (NN improvement)) (PP (IN of) (NP (NP (NNS patients) (POS ')) (NN survival) (NN rate)))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NNS pathologists)) (VP (MD can) (ADVP (RB only)) (ADVP (RB visually)) (VP (VB detect) (NP (NN signet) (NN ring) (NNS cells)) (PP (IN under) (NP (DT the) (NN microscope))))) (. .))
(S (NP (DT This) (NN procedure)) (VP (VBZ is) (RB not) (ADVP (RB only)) (ADJP (JJ laborious) (CONJP (CC but) (RB also)) (JJ prone)) (PP (IN to) (NP (NN omission)))) (. .))
(S (NP (DT An) (ADJP (JJ automatic) (CC and) (JJ accurate)) (NML (NN signet) (NN ring)) (NML (NN cell) (NN detection)) (NN solution)) (VP (VP (VBZ is) (ADVP (RB thus)) (ADJP (JJ important))) (CC but) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN investigated) (ADVP (RB before)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP take) (NP (DT the) (JJ first) (NN step)) (S (VP (TO to) (VP (VB present) (NP (DT a) (JJ semi-supervised) (NN learning) (NN framework)) (PP (IN for) (NP (DT the) (NN signet) (NN ring) (NN cell) (NN detection) (NN problem))))))) (. .))
(S (S (NP (NN Self) (HYPH -) (NN training)) (VP (VBZ is) (VP (VBN proposed) (S (VP (TO to) (VP (VB deal) (PP (IN with) (NP (NP (DT the) (NN challenge)) (PP (IN of) (NP (JJ incomplete) (NNS annotations))))))))))) (, ,) (CC and) (S (NP (JJ cooperative) (HYPH -) (NN training)) (VP (VBZ is) (VP (VBN adapted) (S (VP (TO to) (VP (VB explore) (NP (DT the) (JJ unlabeled) (NNS regions)))))))) (. .))
(S (S (VP (VBG Combining) (NP (DT the) (CD two) (NNS techniques)))) (, ,) (NP (PRP$ our) (JJ semi-supervised) (NN learning) (NN framework)) (VP (MD can) (VP (VB make) (NP (NP (JJR better) (NN use)) (PP (IN of) (NP (DT both) (ADJP (VBN labeled) (CC and) (JJ unlabeled)) (NNS data)))))) (. .))
(S (NP (NP (NNS Experiments)) (PP (IN on) (NP (JJ large) (JJ real) (JJ clinical) (NNS data)))) (VP (VBP demonstrate) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (PRP$ our) (NN design))))) (. .))
(S (NP (PRP$ Our) (NN framework)) (VP (VP (VBZ achieves) (NP (JJ accurate) (NN signet) (NML (NN ring) (NN cell)) (NN detection))) (CC and) (VP (MD can) (VP (VB be) (ADVP (RB readily)) (VP (VBN applied) (PP (IN in) (NP (DT the) (JJ clinical) (NNS trails))))))) (. .))
(S (NP (DT The) (NN dataset)) (VP (MD will) (VP (VB be) (VP (VBN released) (ADVP (RB soon)) (S (VP (TO to) (VP (VB facilitate) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT the) (NN area)))))))))) (. .))
